Atlas Trials

High-risk Myelodysplastic Syndrome (MDS)

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-risk Myelodysplastic Syndrome (MDS)

RecordFirmDate
Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital (NCT06681363)Nantes University Hospital2026-05-21
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) (NCT03940352)Novartis Pharmaceuticals2019-06-24
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT03787498)Opna Bio LLC2019-03-19
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT02198482)University of Ulm2016-02-01

Track High-risk Myelodysplastic Syndrome (MDS) automatically

Every clearance here is in the API, with alerts when new ones post.